cobalt has been researched along with flufenamic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adame, A; Crews, L; Dallapiccola, B; Marongiu, R; Masliah, E; Patrick, C; Spencer, B; Trejo, M; Valente, EM | 1 |
| Hatzidimitriou, AG; Kefala, LA; Kessissoglou, DP; Papadopoulos, AN; Perdih, F; Psomas, G; Tsiliou, S; Turel, I | 1 |
| Kaluđerović, GN; Morgan, I; Samoľová, E; Saoud, M; Smolko, L; Smolková, R | 1 |
3 other study(ies) available for cobalt and flufenamic acid
| Article | Year |
|---|---|
Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.
Topics: Adenosine Triphosphate; Alanine; alpha-Synuclein; Analysis of Variance; Animals; Calcium; Cell Line, Tumor; Cobalt; Dose-Response Relationship, Drug; Flufenamic Acid; Gene Expression Regulation; Green Fluorescent Proteins; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Mitochondria; Mutation; Neuroblastoma; Neurons; Protein Kinases; Rats; Threonine; Transfection; Tryptophan | 2009 |
Cobalt(II) complexes with non-steroidal anti-inflammatory drugs and α-diimines.
Topics: 2,2'-Dipyridyl; Aminopyridines; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Biphenyl Compounds; Cations, Divalent; Cobalt; Coordination Complexes; Crystallography, X-Ray; Diflunisal; DNA; Flufenamic Acid; Free Radical Scavengers; Intercalating Agents; Kinetics; Mefenamic Acid; Methanol; Models, Molecular; Niflumic Acid; Phenanthrolines; Picrates; Serum Albumin | 2016 |
Two isostructural Co(II) flufenamato and niflumato complexes with bathocuproine: Analogues with a different cytotoxic activity.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cobalt; Coordination Complexes; Drug Screening Assays, Antitumor; Flufenamic Acid; G1 Phase Cell Cycle Checkpoints; Humans; Ligands; Molecular Structure; Phenanthrolines; Structure-Activity Relationship | 2020 |